View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pharmatest
8 June 2017

Pharmatest Establishes Subsidiary in US

Pharmatest Services LLC is newly established US based contract research organization (CRO) operating in Massachusetts. It offers preclinical efficacy services in oncology and skeletal diseases. The company is a fully owned subsidiary of Pharmatest Services Ltd based in Finland.

In skeletal diseases, Pharmatest offers models of osteoporosis and osteoarthritis. In oncology Pharmatest has special expertise in clinically predictive orthotopic and metastasis models. The company has been a global provider of models of bone metastasis since 2007. As bone experts, Pharmatest also offers bone safety studies.

Chief executive officer (CEO) of Pharmatest Jussi Halleen comments: "Our US sales have grown more than 50% per year in the past years. We expect the growth to continue also in the coming years, and we established the LLC to be able to better serve our US customers. When the business grows it is our long-term goal to offer more jobs for skilled people in the US."

Andrew Heiniluoma is the manager of Pharmatest Services LLC and responsible for the operations. He says: "I am thrilled to see how the expertise and high-quality preclinical services of Pharmatest will help American drug development companies to save time, money and effort, and at the same time develop compounds that are more effective in the clinic."

Join Pharmatest for an educational seminar about the importance of preclinical bone metastasis studies in Boston on 6 September in an event held together with Taconic Biosciences.

4T1 is a triple-negative mouse breast cancer cell line. Pharmatest utilises a 4T1 cell line with stable expression of green fluorescent protein (GFP) enabling easy...
Metastatic and primary tumours are known to respond differently to chemotherapy. Therefore, when establishing drug efficacy it is important not to rely only on experiments...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology